Latest Zimmer Biomet News & Updates

See the latest news and media coverage for Zimmer Biomet. We track all announcements, press releases, and industry mentions in real time, all in one place.

Zimmer Biomet

Orthopedic medical technology company

zimmerbiomet.com

Headquarters: Warsaw, United States
Company type: Public company
Number of employees: 15,000+
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about Zimmer Biomet

In short: Zimmer Biomet reported strong 2026 financial growth, expanded its robotic and AI portfolios, and underwent several leadership transitions.

Company announcements

July 15 Zimmer Biomet

Zimmer Biomet joins musculoskeletal health partnership in Indiana

The NSF IMPACT Engine aims to accelerate development and commercialization of musculoskeletal technologies, strengthening Indiana's orthopedics leadership.

July 14 Zimmer Biomet

Zimmer Biomet names Chintan Desai President of Asia Pacific Region

He is a seasoned MedTech executive with nearly three decades of experience and replaces Sang Yi.

June 25 Zimmer Biomet

Zimmer Biomet announced Japan approval of first iodine hip implant

The non-antibiotic technology reduces bacterial adhesion on implant surfaces, and the company spoke with the first patient and Professor Hiroyuki Tsuchiya.

June 4 Zimmer Biomet

Zimmer Biomet receives FDA clearance for OrthoGrid Hip AI 4.0

The AI-powered tool offers improved accuracy and real-time features for hip arthroplasty.

Media coverage

July 28 GuruFocus

ZBH Assumed by UBS -- Price Target Raised to $115.00

Zimmer Biomet Holdings (ZBH) Analyst Rating Update On October 03, 2023, UBS has assumed coverage on Zimmer Biomet Holdings (ZBH) with a rating of "Buy."...

July 28 Investing.com

UBS initiates Zimmer Biomet stock coverage with buy rating By Investing.com

The investment bank said Zimmer Biomet trades at approximately 10.1 times 2027 price-to-earnings ratio. UBS believes the market underestimates the company’s growth potential, projecting mid-single-digit...

July 28 Kalkine Media

What Boosted Zimmer Biomet (NYSE:ZBH) Quarterly Revenue?

Zimmer Biomet reported quarterly results highlighting orthopaedic devices, robotic surgery technologies, healthcare operations, and S&P 500 medical technology developments across global markets today.

July 28 Seeking Alpha

Zimmer upgraded to Buy from Sell at UBS on growth and innovation

Zimmer Biomet (ZBH) stock gains as UBS upgrades the company to Buy from Sell citing its growth prospects and innovation.

Never miss news about Zimmer Biomet

Track Zimmer Biomet and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Zimmer Biomet competitors & trending companies

Browse news for competitors to Zimmer Biomet and other trending companies.